データなし
データなし
Scilex Holding Shares Are Trading Lower After the Company Announced That Ernst & Young Requested an Audit Committee Investigation Into Contracts From June and September 2024. The Audit Committee Determined to Dismiss Ernst & Young Effective Immediately.
Pleasing Signs As A Number Of Insiders Buy Scilex Holding Stock
Scilex Announced It Had A Successful End Of Phase II Meeting With The FDA Leading To An Agreed Path Forward To NDA Upon Completion Of Phase III Trials For Blockbuster Product Candidate, SP-103 (Lidocaine Topical System) 5.4% For The Treatment Of...
Press Release: Scilex Holding Company, Following Its Prior Announcement of the Record Date for a Dividend of Preferred Stock, Reiterates Information Previously Provided to Scilex Stockholders Regarding Manipulative and Naked Short Selling of Scilex...
Scilex Holding Price Target Maintained With a $7.00/Share by HC Wainwright & Co.
Scilex Explores Strategic Options, Analyst Initiates On Blockbuster Potential For Sciatica Pain Candidate
データなし
データなし